Phenobarbital for Acute Alcohol Withdrawal

• Status: Completed
• Trial end date: 2010-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Intravenous phenobarbital in combination with a symptom-guided standardized lorazepam-based alcohol withdrawal protocol will be associated with decreased need for ICU admission, continuous lorazepam infusion and will not be associated with increased adverse events.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jonathan Rosenson
• Collaborator: Alameda County Medical Center
• Treatments: Phenobarbital

Criteria

Inclusion Criteria:

• Need for admission to hospital for acute alcohol withdrawal

Exclusion Criteria:

• allergy to phenobarbital, lorazepam, age<18 or >65